Chlorosphaerolactylates A–D: Natural Lactylates of Chlorinated Fatty Acids Isolated from the Cyanobacterium Sphaerospermopsis sp. LEGE 00249

Chlorosphaerolactylates A–D: Natural Lactylates of Chlorinated Fatty Acids Isolated from the Cyanobacterium Sphaerospermopsis sp. LEGE 00249

Four natural lactylates of chlorinated fatty acids, chlorosphaerolactylates A–D (1–4), were isolated from the methanolic extract of the cyanobacterium Sphaerospermopsis sp. LEGE 00249 through a combination of bioassay-guided and MS-guided approaches. Compounds 1–4 are esters of (mono-, di-, or tri)­...

Full description

Saved in:
Bibliographic Details
Published in:Journal of natural products (Washington, D.C.) Vol. 83; no. 6; pp. 1885 - 1890
Main Authors: Gutiérrez-del-Río, Ignacio, Brugerolle de Fraissinette, Nelly, Castelo-Branco, Raquel, Oliveira, Flavio, Morais, João, Redondo-Blanco, Saúl, Villar, Claudio J, Iglesias, María José, Soengas, Raquel, Cepas, Virginio, Cubillos, Yuly López, Sampietro, Giacomo, Rodolfi, Liliana, Lombó, Felipe, González, Sara M. Soto, López Ortiz, Fernando, Vasconcelos, Vitor, Reis, Mariana A
Format: Journal Article
Language:English
Published: American Chemical Society and American Society of Pharmacognosy 26-06-2020
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Four natural lactylates of chlorinated fatty acids, chlorosphaerolactylates A–D (1–4), were isolated from the methanolic extract of the cyanobacterium Sphaerospermopsis sp. LEGE 00249 through a combination of bioassay-guided and MS-guided approaches. Compounds 1–4 are esters of (mono-, di-, or tri)­chlorinated lauric acid and lactic acid, whose structures were assigned on the basis of spectrometric and spectroscopic methods inclusive of 1D and 2D NMR experiments. High-resolution mass-spectrometry data sets also demonstrated the existence of other minor components that were identified as chlorosphaero­(bis)­lactylate analogues. The chlorosphaerolactylates were tested for potential antibacterial, antifungal, and antibiofilm properties using bacterial and fungal clinical isolates. Compounds 1–4 showed a weak inhibitory effect on the growth of Staphylococcus aureus S54F9 and Candida parapsilosis SMI416, as well as on the biofilm formation of coagulase-negative Staphylococcus hominis FI31.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0163-3864
1520-6025
DOI:10.1021/acs.jnatprod.0c00072